| Attributes | Values |
|---|
| rdf:type
| |
| description
| - videnskabelig artikel (da)
- article científic (ca)
- articolo scientifico (it)
- artigo científico (pt)
- bilimsel makale (tr)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- научни чланак (sr)
- article scientifique (fr)
- artículu científicu espublizáu en 2008 (ast)
- наукова стаття, опублікована в травні 2008 (uk)
- مقالة علمية نشرت في مايو 2008 (ar)
- scientific article published on May 2008 (en)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| author name string
| |
| author name string
| - M Naumann
- D M Simpson
- Y So
- L L Simpson
- J M Miyasaki
- B Russman
- H K Graham
- J-M Gracies
|
| rdfs:label
| - Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (en)
- Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (ast)
- Assessment: Botulinum neurotoxin for the treatment of spasticity (nl)
|
| skos:prefLabel
| - Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (en)
- Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (ast)
- Assessment: Botulinum neurotoxin for the treatment of spasticity (nl)
|
| name
| - Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (en)
- Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (ast)
- Assessment: Botulinum neurotoxin for the treatment of spasticity (nl)
|
| author
| |
| author
| |
| title
| |
| title
| - Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1212/01.WNL.0000311391.00944.C4
|
| ResearchGate publication ID
| |
| ResearchGate publication ID
| |
| is about
of | |
| is cites work
of | - Botulinum toxin for neuropathic pain and spasticity: an overview
- Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache
- Development of treatment concepts for the use of botulinum toxin a in children with cerebral palsy
- [Botulinum toxin A in children with infantile cerebral palsy: indications and treatment concepts].
- Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT/A).
- Effects of botulinum toxin A on calf muscles in children with cerebral palsy: a systematic review
- Clinical relevance of botulinum toxin immunogenicity
- Botulinum toxin for symptomatic therapy in multiple sclerosis
- Botulinum toxin injection into the forearm muscles for wrist and fingers spastic overactivity in adults with chronic stroke: a randomized controlled trial comparing three injection techniques.
- Cerebral palsy
- Rehabilitation in practice: Spasticity management
- Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence
- Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial
- A retrospective study to assess resource utilization in patients with cervical dystonia in the United Kingdom
- Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis
- Guidelines for the use of botulinum toxin in movement disorders and spasticity
- Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the
- Kinematic improvement following Botulinum Toxin-A injection in upper-limb spasticity due to stroke
- Botulinum toxin: bioweapon & magic drug
- The use of botulinum toxin type A in the management of adult-onset focal spasticity: a survey of Australian allied health professionals.
- Intrinsic properties and functional changes in spastic muscle after application of BTX-A in children with cerebral palsy: systematic review
- Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders
- Two-dimensional and shear wave elastography ultrasound: A reliable method to analyse spastic muscles?
- Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer.
- Diffusion, spread, and migration of botulinum toxin
- Treatment of proximal upper limb tremor with botulinum toxin therapy.
- Targeted secretion inhibitors-innovative protein therapeutics
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)